us-abfm MCQ (SBA): Cardiovascular Risk Reduction in T2D

Instant feedback + full explanation. One question, done properly.

EasyEndocrinologyCardiovascular Risk Reduction in T2Dus-abfmus-abimus-usmle-step-2

A 55-year-old with obesity and T2D on metformin has A1C 7.5%. eGFR 70, UACR 25 mg/g. What adds CV benefit independent of A1C?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.

us-abfm MCQ: Cardiovascular Risk Reduction in T2D — Answer & Explanati